(MedPage Today) -- A combination of direct-acting antiviral agents aimed at hepatitis C -- and given without standard therapy -- can lead to sustained virologic response in patients with a difficult-to-treat strain of the virus.
New Combo KOs HCV Without Interferon, Ribavirin (CME/CE)Courtesy MedPage Today Infectious Disease Wed, 01/18/2012 - 15:00
(MedPage Today) -- A combination of direct-acting antiviral agents aimed at hepatitis C -- and given without standard therapy -- can lead to sustained virologic response in patients with a difficult-to-treat strain of the virus. More related itemsDDW: Telaprevir Improves HCV Clearance in Resistant...
AASLD: Milk Thistle No Help in Chronic HCV (CME/CE)
AASLD: New PI Effective, Safe in HCV Trial (CME/CE)
Numi's Bouquet Bamboo Gift Set with Clear Teapot and...
Mania By Giorgio Armani For Men. Eau De Toilette...
|
Popular by tags WeekMonth |
Post new comment